Archives of Disease in Childhood · 1988 · 73 citations · 14 references
MedicineDermatologyNeurologyNeuro-ophthalmologyPediatric DermatologyVisual DisordersAmino Acid Metabolism DisordersEnzyme DeficienciesMetabolic Pathway DefectsPigmentary DisordersBiotinidase DeficiencyEnzyme Deficiency DisordersMetabolic Deficiency DisordersNeurological DeteriorationNeurological EtiologyPediatric Neurological DamageResidual Damage Assessment
Ten patients with biotinidase deficiency were studied. Clinical findings at presentation varied with dermatological signs (dermatitis and alopecia), neurological abnormalities (fits, hypotonia, and ataxia), and recurrent infections being the most common features, although none of these occurred in every case. Biochemically the disease is characterised by metabolic acidosis and organic aciduria. Treatment with biotin results in pronounced, rapid, clinical and biochemical improvement, but some patients have residual neurological damage comprising neurosensory hearing loss, visual pathway defects, ataxia, and mental retardation. The cause of this permanent damage remains obscure and it is not clear if the early introduction of treatment will prevent it.
14
DOES SCREENING BY "PAP" SMEARS HELP PREVENT CERVICAL CANCER?
Emily A Clarke, T.W. Anderson · The Lancet · 1979 · 252 citations
Phenotypic variation in biotinidase deficiency
Barry Wolf, Robert E. Grier, Richard J. Allen et al. · The Journal of Pediatrics · 1983 · 196 citations
B Burri, Lawrence Sweetman, William L. Nyhan · Journal of Clinical Investigation · 1981 · 148 citations · Full text